| Revenue growth | Double-digit in Sugar Free, Everyuth, and Nutralite portfolios. |
|---|---|
| Margins | EBITDA expansion in protein snacking; input costs managed through disciplined pricing. |
| Demand visibility | Strong in Q-commerce and e-commerce; premiumization trend driving higher-value shifts. |
| Management confidence | High; citing market leadership and outperforming category growth in most brands. |
Growth
Sugar Free and Everyuth delivered double-digit growth. Everyuth moved from 5th to 4th rank in facial cleansing with 8.2% market share.
Outlook
Focus on scaling 'RiteBite Max Protein' and 'Complan NutriGro'. Strategic expansion into UK via Comfort Click Limited acquisition.
Risks
Unseasonal rainfall in North and East India impacted seasonal demand for Glucon-D and Nycil. Divergent commodity costs managed via pricing.
Last quarter's promises, checked
Delivered
- Guided double-digit growth for Everyuth → delivered double-digit growth (= BEAT)
- Guided market share expansion for Sugar Free → delivered 24 bps expansion (= BEAT)
- Guided EPS accretion for Comfort Click in Q4 → delivered EPS accretive (= BEAT)
Partly delivered
- Guided recovery in seasonal portfolio from May → delivered weather-related headwinds in Q1 (= PARTIAL)
Missed
- Guided double-digit growth for seasonal brands → delivered 9.8% decline (= MISS)
- Guided EBITDA margin of 17-18% → delivered lower than aspiration (= MISS)
Investor Presentation filed with NSE, NSE: ZYDUSWELL. Summary written with AI assistance from the document.
Zydus Wellness Ltd: key numbers
- Share price
- ₹471.45
- Market cap
- ₹15,000 Cr
- Revenue (annual)
- ₹3,961 Cr
- Net profit (annual)
- ₹197.2 Cr
- P/E (TTM)
- 61.0×Sector 41.3×
- Promoter holding
- 69.64%+0.00% QoQ
- FII holding
- 3.57%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zydus Wellness Ltd
All →Zydus Wellness Earnings Call Transcript: Key Takeaways
Consolidated sales rose 74.6% to ₹1,122.7 Cr, aided by the Comfort Click acquisition. Domestic grew 29.2% in Q2 but only 13.3% in H1. Management gave no Comfort Click margin figures when pressed.
Zydus Wellness Results Update
Zydus Wellness reported Q2 FY27 consolidated net sales of ₹11,227 million, up 74.6% YoY. EBITDA grew 271.7% to ₹855 million on strong brand momentum.
Zydus Wellness Investor Presentation: Key Takeaways
Q2 FY27 deck discloses no group P&L numbers. Brands report double-digit growth (Nutralite, Sugar Free, Complan, Everyuth), Max Protein EBITDA expanded, and no guidance is given.
Zydus Wellness Q2 FY27 Results: Turns Profitable, Net Profit ₹5.1 Cr
Zydus Wellness Ltd reported revenue from operations of ₹1,127 Cr (+73.2% YoY) and net profit of ₹5.1 Cr for Q2 FY27.
- Key figure
- Net profit ₹5.1 Cr
Zydus Wellness Price Movement Clarification
Zydus Wellness clarified that it received a notice from FSSAI regarding alleged misleading product claims. The company stated that its labels are factual and supported by scientific substantiation.
Zydus Wellness Other Announcement
Zydus Wellness Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.